IL10 and Alzheimer disease: Specifically, we found a significant increase in the levels of IL-4 (p = 0.024), IL-10 (p = 0.040) and G-CSF (p = 0.046) in AD patients with a fast cognitive decline compared to slow cognitive decline in ADAS-cog over one year (Figure 2 and Table 5).